Survodutide 10 mg

Dragon Pharma Survodutide

For athletes, bodybuilders, and fitness enthusiasts seeking cutting-edge tools for body composition optimization, metabolic regulation, and energy expenditure, Survodutide represents a significant advancement in peptide research. As a dual agonist targeting both glucagon-like peptide-1 (GLP-1) and glucagon receptors, Survodutide offers a unique mechanism that combines appetite suppression with enhanced energy expenditure—a combination that distinguishes it from other metabolic research compounds. This Dragon Pharma Survodutide 10mg offering delivers high-purity lyophilized powder in a sterile 2mL vial, providing researchers with a premium compound for advanced metabolic and body composition research.

Survodutide functions through simultaneous activation of GLP-1 and glucagon receptors. GLP-1 agonism suppresses appetite, delays gastric emptying, and improves insulin sensitivity, while glucagon agonism increases energy expenditure, promotes lipolysis (fat breakdown), and enhances hepatic fatty acid oxidation. This dual mechanism creates a powerful synergistic effect that research suggests produces superior metabolic outcomes compared to single-receptor agonists. Clinical research published in the NIH PubMed database demonstrates that Survodutide produces significant reductions in body weight, improved liver health markers, and enhanced metabolic parameters, with Phase 2 trials showing promising results for both weight management and metabolic dysfunction-associated steatotic liver disease (MASLD) research.

The relevance of Survodutide to the athletic and bodybuilding community is substantial. For competitors navigating cutting phases, the combination of appetite suppression and increased energy expenditure creates an optimal environment for fat loss while preserving lean muscle mass. The glucagon component is particularly significant, as it directly promotes fatty acid oxidation and thermogenesis—mechanisms that support fat loss without compromising muscle tissue when properly managed. Additionally, Survodutide's effects on hepatic metabolism make it valuable for athletes concerned with liver health, particularly those who have utilized oral androgens or other compounds that may impact liver function. Its once-weekly dosing profile also offers convenience for research protocols.

Quality assurance is paramount in peptide research. Each batch of our Survodutide 10 mg inventory undergoes rigorous third-party HPLC-MS testing to verify purity and dosage. The most recent batch (September 2024) tested at 9.68 mg with batch number #SVDHD7, exceeding label claims and demonstrating Dragon Pharma's commitment to quality. This level of transparency ensures that researchers can trust the integrity of the compounds they are investigating.

For bodybuilders and strength athletes seeking advanced metabolic research tools, Survodutide offers a unique dual-agonist mechanism that addresses both sides of the energy balance equation—caloric intake through GLP-1 agonism and energy expenditure through glucagon agonism. Whether investigating strategies for contest preparation, metabolic health optimization, or sustainable weight management, Dragon Pharma's Survodutide delivers the purity, potency, and reliability required for serious research into next-generation metabolic pathways.

Note: This product is intended for laboratory research and scientific investigation purposes only. Not for human consumption or veterinary use.

Product Specifications

Usage Guidelines

Survodutide is supplied as a sterile lyophilized powder and must be reconstituted with bacteriostatic water prior to research use. For optimal stability, gently swirl the vial after adding the diluent—do not shake vigorously. Standard research protocols involve reconstituting the 10mg peptide with 2-4mL of bacteriostatic water, yielding a concentration of 2.5-5mg/mL. Typical research dosing in clinical studies ranges from 0.6-4.8mg per week, administered as a single weekly subcutaneous injection with gradual dose titration to assess tolerance. Due to its extended half-life, Survodutide is designed for once-weekly administration. It is recommended to store the reconstituted peptide in a refrigerator (2-8°C) and use within 28 days to maintain peptide integrity. For optimal research outcomes, administer on an empty stomach or as directed by protocol.

For researchers investigating comprehensive metabolic and body composition protocols, combining Survodutide with complementary compounds can yield synergistic insights. Consider exploring the following Dragon Pharma products to enhance your research:

• Cagrilintide Acetate: An amylin analog studied alongside dual agonists for enhanced metabolic outcomes.
• AOD 9604: A lipolytic peptide fragment studied for its complementary effects on fat metabolism.

Third-Party Lab Results

2024-09-13

View Certificate

9.68 mg

Shipping & Authenticity

• From USA Domestic warehouse: 2-5 business days.
• From International warehouse: 14-21 business days.
• Free and automatic re-shipping policy if package doesn't reach destination within 30 days.
• Original product directly from manufacturer.
• We accept credit cards and cryptocurrency—crypto payments receive an additional 20% discount at checkout.

Storage Instructions

To maintain maximum stability and potency of the lyophilized powder, store the unopened vial in a freezer at -20°C (-4°F) away from light. Upon reconstitution with bacteriostatic water, the solution must be stored in a refrigerator at 2-8°C (36-46°F) and should be used within 28 days. Avoid repeated freeze-thaw cycles as this may degrade the peptide structure.

Frequently Asked Questions